My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

SCYNEXIS, Inc. - Common Stock (NQ:SCYX)

0.7500 -0.0271 (-3.49%)

Streaming Delayed Price Updated: 4:00 PM EST, Feb 13, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about SCYNEXIS, Inc. - Common Stock

< Previous 1 2 3 4 Next >

SCYNEXIS Shares Climb As FDA Accepts Filing For Vaginal Yeast Infection Candidate Under Priority Review ↗

August 01, 2022

SCYNEXIS (NASDAQ: SCYX) announced that the U.S. Food and Drug Administration (FDA) has accepted its submission of a supplemental New Drug Application (sNDA) to expand the label of BREXAFEMME...

Via Benzinga

Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday ↗

July 21, 2022

Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.

Via Benzinga

Scynexis Touts Postive Data For Ibrexafungerp For Vaginal Infections ↗

July 19, 2022

Via Benzinga

SCYNEXIS: Q1 Earnings Insights ↗

May 12, 2022

SCYNEXIS (NASDAQ:SCYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Scynexis's Oral Ibrexafungerp Shows Potency Against Severe Fungal Infections ↗

April 22, 2022

Via Benzinga

This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session ↗

July 20, 2022

Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...

Via Benzinga

Recap of Tuesday's Biotech Catalysts - End Of The Day Summary ↗

July 19, 2022

The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...

Via Benzinga

Recap: SCYNEXIS Q4 Earnings ↗

March 29, 2022

SCYNEXIS (NASDAQ:SCYX) reported its Q4 earnings results on Tuesday, March 29, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 16, 2022

Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Outlook For SCYNEXIS ↗

May 11, 2022

SCYNEXIS (NASDAQ:SCYX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that SCYNEXIS will...

Via Benzinga

Mid-Afternoon Market Update: Dow Dips Over 800 Points; HCA Healthcare Shares Plunge ↗

April 22, 2022

U.S. stocks extended losses toward the end of trading, with the Dow Jones dropping more than 800 points on Friday.

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

55 Biggest Movers From Friday ↗

April 25, 2022

Gainers Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) shares jumped 100.9% to close at $2.27 on Friday. Vallon Pharmaceuticals engaged Ladenburg Thalmann & Co Inc to evaluate...

Via Benzinga

Mid-Day Market Update: Nasdaq Down 200 Points; Blueknight Shares Spike Higher ↗

April 22, 2022

U.S. stocks extended losses midway through trading, with the Nasdaq Composite dropping 200 points on Friday.

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Tumbles 400 Points ↗

April 22, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Friday.

Via Benzinga

The Daily Biotech Pulse: WHO Endorses Pfizer's Oral COVID Therapy, Vallon Pharma Surges On Strategic Review, Novavax Starts Dosing In Adolescents COVID Booster Trial ↗

April 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 22, 2022

Gainers Vallon Pharmaceuticals (NASDAQ:VLON) shares moved upwards by 94.7% to $2.2 during Friday's pre-market session. The company's market cap stands at $14.9 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

April 22, 2022

Traders ready for another busy day of investing will want to know all about the biggest pre-market stock movers for Friday!

Via InvestorPlace

22 Stocks Moving in Friday's Pre-Market Session ↗

April 22, 2022

Gainers Moving iMage Technologies, Inc. (NASDAQ: MITQ) rose 41.7% to $1.63 in pre-market trading. Moving iMage Technologies and SNDBX reported a strategic partnership for gaming...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 21, 2022

Gainers

Via Benzinga

Why Scynexis Shares Are Falling During Thursday's After-Hours Session ↗

April 21, 2022

SCYNEXIS Inc (NASDAQ: SCYX) shares are trading lower after the company announced a public offering of common stock. The size of the offering was not disclosed.

Via Benzinga

36 Stocks Moving In Tuesday's Mid-Day Session ↗

March 29, 2022

Gainers China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) jumped 88.1% to $0.38 after declining 9% on Monday. McCormick (NASDAQ: IGMS) shares jumped 49.8% to $22.46. Sanofi SA (...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

April 21, 2022

On Thursday, 236 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

April 20, 2022

On Wednesday, 160 companies hit new 52-week lows. Areas of Significance In Today's 52-Week Lows: Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...

Via Benzinga

53 Biggest Movers From Yesterday ↗

March 30, 2022

Gainers IGM Biosciences, Inc. (NASDAQ: IGMS) shares gained 96.7% to settle at $29.49 on Tuesday. Sanofi SA (NASDAQ: SNY) and IGM Biosciences signed an exclusive worldwide...

Via Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia ↗

March 29, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Earnings Scheduled For March 29, 2022 ↗

March 29, 2022

Companies Reporting Before The Bell • 36KR Holdings (NASDAQ:KRKR) is projected to report quarterly loss at $0.02 per share on revenue of $15.62 million.

Via Benzinga

Earnings Preview: SCYNEXIS ↗

March 28, 2022

SCYNEXIS (NASDAQ:SCYX) is set to give its latest quarterly earnings report on Tuesday, 2022-03-29. Here's what investors need to know before the announcement. Analysts estimate that SCYNEXIS will...

Via Benzinga

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More ↗

March 27, 2022

Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.